Validation of the Madrid Genotype Score to Predict Pathogenic Variants in U.S. Dilated Cardiomyopathy Patients.

Resnick R, Kao EY, Maynard C, Tabaghi S, Stergachis AB, Nazer B, Yang KD

Open source

DOI
10.1016/j.jacadv.2026.102648
Published
2026 Apr
Container
JACC. Advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacadv.2026.102648,
  title = {Validation of the Madrid Genotype Score to Predict Pathogenic Variants in U.S. Dilated Cardiomyopathy Patients.},
  author = {Resnick R and Kao EY and Maynard C and Tabaghi S and Stergachis AB and Nazer B and Yang KD},
  year = {2026},
  journal = {JACC. Advances},
  doi = {10.1016/j.jacadv.2026.102648},
  url = {https://doi.org/10.1016/j.jacadv.2026.102648}
}

RIS

TY  - JOUR
TI  - Validation of the Madrid Genotype Score to Predict Pathogenic Variants in U.S. Dilated Cardiomyopathy Patients.
AU  - Resnick R
AU  - Kao EY
AU  - Maynard C
AU  - Tabaghi S
AU  - Stergachis AB
AU  - Nazer B
AU  - Yang KD
PY  - 2026
JO  - JACC. Advances
DO  - 10.1016/j.jacadv.2026.102648
UR  - https://doi.org/10.1016/j.jacadv.2026.102648
ER  - 

APA

R, R., EY, K., C, M., S, T., AB, S., B, N., & KD, Y. (2026). Validation of the Madrid Genotype Score to Predict Pathogenic Variants in U.S. Dilated Cardiomyopathy Patients.. JACC. Advances. https://doi.org/10.1016/j.jacadv.2026.102648

Source records